shopping cart
nothing in cart
 
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
home
about us
upcoming events
Dec 3rd - Collaborative and Proactive Solutions at School: Moving from power and control to collaboration and problem solving [SickKids CCMH Learning Institute]
Dec 11th - ONTABA 2020 Annual Conference [ONTABA - Ontario Association for Behaviour Analysis]
May 1st - American Psychiatric Association 174th annual meeting, Los Angeles [APA]
Jun 17th - IARPP Conference 2021 - Expanding Our Clinical Experiences: The Spoken, Unspoken and Unspeakable in Relational Psychoanalysis and Psychotherapy [IARPP]
Jul 9th - 28th Annual OCD Conference [International OCD Foundation]
schools agencies and other institutional orders (click here)
Due to Covid-19, we are now open only for deliveries and pickups. Still free shipping across Canada for orders over $50. Please read our Covid-19 statement here.
Join our mailing list! Click here to sign up.
Neurobiology of Depression
Lopez-Muinoz, F. (Edt)
CRC Press / Hardcover / 2011-09-01 / 1439838496
Neuroscience / Psychiatry
price: $288.50 (may be subject to change)
Not in Stock, usually ships in 3-6 business days

Major depressive disorders have recently been associated with impairments in signaling pathways that regulate neuroplasticity and cell survival. Agents designed to directly target molecules in these pathways hold promise as new therapeutics for depression. With the collaboration of the most prestigious international specialists in biochemistry, molecular biology, genomics, psychiatry, psychology, and pharmacology, Neurobiology of Depression discusses the nature of the central nervous system circuits responsible for the modifications of neuronal functioning that lead to depression.

The book begins by discussing animal, neurophysiological, and neuropsychological models of depression as well as neural foundations. It explores genetic factors that contribute to depression and describes the effect of monoaminergic systems in the central nervous system.

Next, the book profiles the rise of psychopharmacology in the treatment of depression and the research into serotonin and monoamine reuptake inhibitors. It examines the role of the glutamatergic, endocannabinoid, and opioid systems in the pathophysiology of mood disorders, as well as the effect of biological rhythms on the human body.

Later chapters review the role of CRF-related ligands, CRF receptors, HPA axis activity, and glucocorticoid receptors in the regulation of the stress response and depression. They also describe cytokine modulation of molecular mechanisms. They examine the role of neuropeptide Y, nitric oxide, beta-arrestins, BDNF, and phosphodiesterases, and discuss the use of tachykinin antagonists in treatment. Finally, they analyze the neurobiological basis for the development of new antidepressant agents.

Exploring myriad aspects of a disease that plagues a large percentage of the population worldwide, this volume captures the state of the science of this debilitating disorder, facilitating further research and discovery.

Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2020

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
E-mail [email protected]
Hours: 9-6 Mon-Sat / 12-5 Sun (EST)

search
Click here to read previous issues.
other lists
Frontiers in Neuroscience
Neuroscience
Psychiatry